K. Yunoki

1.0k total citations · 1 hit paper
22 papers, 827 citations indexed

About

K. Yunoki is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, K. Yunoki has authored 22 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in K. Yunoki's work include T-cell and Retrovirus Studies (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). K. Yunoki is often cited by papers focused on T-cell and Retrovirus Studies (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). K. Yunoki collaborates with scholars based in Japan, United States and France. K. Yunoki's co-authors include Michito Ichimaru, Masahiro Kikuchi, Y Takiuchi, Masao Hanaoka, T Takenaka, Haruto Uchino, Toru Chosa, Toshifumi Kondo, Masateru Kohakura and Yorio Hinuma and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

K. Yunoki

21 papers receiving 787 citations

Hit Papers

Antibodies to adult t‐cell leukemia‐virus‐associated anti... 1982 2026 1996 2011 1982 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Yunoki Japan 9 716 541 518 85 63 22 827
J Minowada Japan 9 513 0.7× 323 0.6× 345 0.7× 81 1.0× 89 1.4× 19 717
Hisashi Sohda Japan 10 413 0.6× 318 0.6× 267 0.5× 52 0.6× 55 0.9× 15 468
H Nagoshi Japan 6 361 0.5× 258 0.5× 187 0.4× 72 0.8× 57 0.9× 12 422
H Umadome Japan 10 432 0.6× 168 0.3× 170 0.3× 41 0.5× 91 1.4× 17 570
Mitsuaki Yoshida Japan 7 472 0.7× 254 0.5× 262 0.5× 33 0.4× 117 1.9× 8 557
Lisa Cabral United States 10 429 0.6× 270 0.5× 251 0.5× 177 2.1× 296 4.7× 16 742
Tatsunori Sakai Japan 7 360 0.5× 196 0.4× 175 0.3× 42 0.5× 97 1.5× 12 573
Harry T. Poteat United States 7 391 0.5× 260 0.5× 274 0.5× 22 0.3× 66 1.0× 10 496
Genji Takeuchi Japan 5 354 0.5× 118 0.2× 75 0.1× 140 1.6× 151 2.4× 7 444
R B Gartenhaus United States 8 159 0.2× 113 0.2× 113 0.2× 43 0.5× 80 1.3× 11 362

Countries citing papers authored by K. Yunoki

Since Specialization
Citations

This map shows the geographic impact of K. Yunoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Yunoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Yunoki more than expected).

Fields of papers citing papers by K. Yunoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Yunoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Yunoki. The network helps show where K. Yunoki may publish in the future.

Co-authorship network of co-authors of K. Yunoki

This figure shows the co-authorship network connecting the top 25 collaborators of K. Yunoki. A scholar is included among the top collaborators of K. Yunoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Yunoki. K. Yunoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohira, Yoshinobu, et al.. (1991). Reduced growth of Ehrlich ascites tumor cells in creatine depleted mice fed β-guanidinopropionic acid. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1097(2). 117–122. 9 indexed citations
2.
Shimoyama, M, Ota K, Masahiro Kikuchi, et al.. (1988). Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia.. Journal of Clinical Oncology. 6(7). 1088–1097. 116 indexed citations
3.
Shimoyama, M, Ota K, Masahiro Kikuchi, et al.. (1988). Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.. Journal of Clinical Oncology. 6(1). 128–141. 99 indexed citations
4.
Shimoyama, M, Masahiro Kikuchi, K. Yunoki, et al.. (1988). Major Prognostic Factors of Adult Patients with Advanced B-Cell Lymphoma Treated with Vincristine, Cyclophosphamide, Prednisone and Doxorubicin (VEPA) or VEPA plus Methotrexate (VEPA-M). Japanese Journal of Clinical Oncology. 18(2). 113–24. 12 indexed citations
5.
Matsumoto, Takao, et al.. (1986). [Immunologic characterization of lymphoid tumor cells from adult T-cell leukemia (ATL) and peripheral T-cell lymphoma (PTCL) in an ATL-endemic area].. PubMed. 27(5). 693–700. 1 indexed citations
6.
Nomura, Kazushi, et al.. (1985). [The outbreak of five lymphoid malignancies in one family during seven years].. PubMed. 26(6). 974–9. 2 indexed citations
7.
Utsunomiya, Atae, T Matsumoto, Masahiro Matsumoto, et al.. (1985). Severe diarrhea and intestinal strongyloidiasis in a patient with adult T-cell leukemia.. PubMed. 48(4). 1109–13. 5 indexed citations
8.
Utsunomiya, Atae, Mitsunobu Matsumoto, Takao Matsumoto, et al.. (1983). A report of a case of T-cell-derived chronic lymphocytic leukemia with antibodies to adult T-cell leukemia-associated antigens.. PubMed. 13 Suppl 2. 291–9. 6 indexed citations
9.
Utsunomiya, Atae, et al.. (1983). Refractory diarrhea in a patient with adult T cell leukemia.. PubMed. 46(4). 1010–5. 3 indexed citations
10.
Matsumoto, Takao, K. Yunoki, Shuichi Hanada, et al.. (1983). Hodgkin's disease in the endemic area of adult T-cell leukemia (ATL).. PubMed. 13 Suppl 2. 301–8. 1 indexed citations
11.
Hinuma, Yorio, Haruko Komoda, Toru Chosa, et al.. (1982). Antibodies to adult t‐cell leukemia‐virus‐associated antigen (atla) in sera from patients with atl and controls in japan: A nation‐wide sero‐epidemiologic study. International Journal of Cancer. 29(6). 631–635. 490 indexed citations breakdown →
12.
Yamagata, Shoichi, A Ishimori, Takeo Wada, et al.. (1970). Gastric Secretion Stimulated by Gastrin-like AOC-tetrapeptide. The Tohoku Journal of Experimental Medicine. 101(2). 103–117. 9 indexed citations
13.
Yunoki, K., et al.. (1968). Gastric secretion in chronic gastritis. Gastroenterologia Japonica. 3(4). 257–258. 1 indexed citations
14.
Yunoki, K., et al.. (1968). Management of Leukemia with Limiting Amino Acid Diet, Especially Low Phenylalanine and Tyrosine Diet (the 2nd Report). The Japanese Journal of Nutrition and Dietetics. 26(1). 39–51. 1 indexed citations
15.
Yunoki, K.. (1967). Secretion of gastric juice in early gastric cancer. Gastroenterologia Japonica. 2(4). 265–277. 1 indexed citations
16.
Yunoki, K., et al.. (1966). An Attempt of Low Phenylalanine Diet Therapy for Chronic Myelogenous Leukemia (Preliminary Report). The Japanese Journal of Nutrition and Dietetics. 24(5-6). 195–204. 5 indexed citations
17.
Yunoki, K., et al.. (1963). Cancer Diagnosis by the Detection of Toxic Factor Peculiar to Cancer. Japanese Journal of Medicine. 2(2). 291–300. 1 indexed citations
18.
Yunoki, K. & A. Clark Griffin. (1961). Composition and properties of a highly purified toxohormone preparation.. PubMed. 21. 537–44. 8 indexed citations
19.
Yunoki, K. & A. Clark Griffin. (1960). Purification of toxohormone by column chromatography.. PubMed. 20. 533–40. 18 indexed citations
20.
Yunoki, K., et al.. (1956). [Studies on the cancer toxin].. PubMed. 47(3-4). 306–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026